Benzinga | Mar 9, 2021 09:15AM EST

Teleflex Highlights 250,000 Patients Treated For Enlarged Prostate With The UroLift System

WAYNE, Pa., March 09, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) today announced that, globally, 250,000 patients have been treated with the UroLift(r) System, a proven, minimally invasive approach to treating benign prostatic hyperplasia (BPH).